The rate of dihydroethidium oxidation was significantly elevated in Gaucher disease, Parkinson’s disease with GBA mutation, non-manifesting carrier and the E326K/E326K fibroblast lines (Fig. 3A). This evidence concerns the gene GBA1 and Parkinson disease.